CytoCore Announces Annual Shareholder Meeting

CHICAGO–(EMWNews)–CytoCore Inc. (OTCBB:CYOE), announced today that the Company’s

2007 Annual Meeting of Stockholders will be held at the Holiday Inn

Chicago Mart Plaza located at 350 W. Mart Center Drive, Chicago, IL,

60654 on Thursday, July 17, 2008 at 10:00 a.m. Central Time.

The annual meeting will also be webcast live on the Internet. Investors

and interested parties that wish to listen to the meeting via the

Internet may do so at the company’s website, www.cytocoreinc.com,

by clicking on the Live Webcast icon labeled “2007 Annual Shareholders

Meeting”. An audio replay will also be available on the company’s

website after the call through Tuesday, July 22, 2008.

About CytoCore Inc.

CytoCore develops cost-effective, highly accurate screening systems for

early detection of gynecological cancers and sexually transmitted

diseases. Designed for easy deployment at a laboratory or at the

point-of-care, the CytoCore suite of sample collection technologies

assists in the detection of cervical, endometrial, and other cancers, as

well as the human Papilloma virus. The CytoCore Solutions™

System is being developed to provide medical practitioners with highly

accurate, low-cost, cervical and uterine cancer screening systems that

can be seamlessly integrated into existing medical models. More

information is available at: www.cytocoreinc.com.

Certain statements in this release are forward-looking. These statements

are based on CytoCore’s current expectations and involve many risks and

uncertainties, such as the company’s inability to obtain sufficient

financing, the possibility that clinical trials will not substantiate

CytoCore’s expectations with respect to the CytoCore Solutions™

System, and other factors set forth in reports and documents filed by

CytoCore with the Securities and Exchange Commission. Actual results may

differ materially from CytoCore’s current expectation depending upon a

number of factors affecting the Company’s business. These factors

include, among others, risks and uncertainties detailed in the Company’s

periodic public filings with the Securities and Exchange Commission,

including but not limited to the Company’s Annual Report on Form 10-KSB

for the year ended December 31, 2007. Except as expressly required by

law, CytoCore undertakes no obligation to publicly update or revise any

forward-looking statements contained herein.

Major Newsire & Press Release Distribution with Basic Starting at only $19 and Complete OTCBB / Financial Distribution only $89

Get Unlimited Organic Website Traffic to your Website 
TheNFG.com now offers Organic Lead Generation & Traffic Solutions